Global and Japan Active Implantable Devices Market Insights, Forecast to 2026

Publisher Name :
Date: 16-Oct-2020
No. of pages: 126
Inquire Before Buying

Active Implantable Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Active Implantable Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Active Implantable Devices market is segmented into

- Implantable Cardioverter Defibrillator

- Implantable Cardiac Pacemakers

- Ventricular Assist Devices

- Implantable Heart Monitors/Insertable Loop Recorders

- Neurostimulators

- Implantable Hearing Devices

Segment by Application, the Active Implantable Devices market is segmented into

- Hospital

- Clinic

Regional and Country-level Analysis

The Active Implantable Devices market is analysed and market size information is provided by regions (countries).

The key regions covered in the Active Implantable Devices market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Active Implantable Devices Market Share Analysis

Active Implantable Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Active Implantable Devices business, the date to enter into the Active Implantable Devices market, Active Implantable Devices product introduction, recent developments, etc.

The major vendors covered:

- LivaNova PLC (U.K.)

- MED-EL (Austria)

- Medtronic (Ireland)

- Abbott Laboratories (U.S.)

- BIOTRONIK (Germany)

- Boston Scientific Corporation (U.S.)

- Cochlear Limited (Australia)

- Nurotron Biotechnology (China)

- Sonova Holding Switzerland)

- William Demant Holding (Denmark)

Global and Japan Active Implantable Devices Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Active Implantable Devices Product Introduction
1.2 Market Segments
1.3 Key Active Implantable Devices Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Active Implantable Devices Market Size Growth Rate by Type
1.4.2 Implantable Cardioverter Defibrillator
1.4.3 Implantable Cardiac Pacemakers
1.4.4 Ventricular Assist Devices
1.4.5 Implantable Heart Monitors/Insertable Loop Recorders
1.4.6 Neurostimulators
1.4.7 Implantable Hearing Devices
1.5 Market by Application
1.5.1 Global Active Implantable Devices Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Active Implantable Devices Market Size, Estimates and Forecasts
2.1.1 Global Active Implantable Devices Revenue 2015-2026
2.1.2 Global Active Implantable Devices Sales 2015-2026
2.2 Global Active Implantable Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Active Implantable Devices Historical Market Size by Region (2015-2020)
2.3.1 Global Active Implantable Devices Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Active Implantable Devices Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Active Implantable Devices Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Active Implantable Devices Sales Forecast by Region (2021-2026)
2.4.2 Global Active Implantable Devices Revenue Forecast by Region (2021-2026)
3 Global Active Implantable Devices Competitor Landscape by Players
3.1 Global Top Active Implantable Devices Sales by Manufacturers
3.1.1 Global Active Implantable Devices Sales by Manufacturers (2015-2020)
3.1.2 Global Active Implantable Devices Sales Market Share by Manufacturers (2015-2020)
3.2 Global Active Implantable Devices Manufacturers by Revenue
3.2.1 Global Active Implantable Devices Revenue by Manufacturers (2015-2020)
3.2.2 Global Active Implantable Devices Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Active Implantable Devices Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Active Implantable Devices Revenue in 2019
3.2.5 Global Active Implantable Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Active Implantable Devices Price by Manufacturers
3.4 Global Active Implantable Devices Manufacturing Base Distribution, Product Types
3.4.1 Active Implantable Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Active Implantable Devices Product Type
3.4.3 Date of International Manufacturers Enter into Active Implantable Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Active Implantable Devices Market Size by Type (2015-2020)
4.1.1 Global Active Implantable Devices Sales by Type (2015-2020)
4.1.2 Global Active Implantable Devices Revenue by Type (2015-2020)
4.1.3 Active Implantable Devices Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Active Implantable Devices Market Size Forecast by Type (2021-2026)
4.2.1 Global Active Implantable Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Active Implantable Devices Revenue Forecast by Type (2021-2026)
4.2.3 Active Implantable Devices Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Active Implantable Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Active Implantable Devices Market Size by Application (2015-2020)
5.1.1 Global Active Implantable Devices Sales by Application (2015-2020)
5.1.2 Global Active Implantable Devices Revenue by Application (2015-2020)
5.1.3 Active Implantable Devices Price by Application (2015-2020)
5.2 Active Implantable Devices Market Size Forecast by Application (2021-2026)
5.2.1 Global Active Implantable Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Active Implantable Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Active Implantable Devices Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Active Implantable Devices Market Size YoY Growth 2015-2026
6.1.1 Japan Active Implantable Devices Sales YoY Growth 2015-2026
6.1.2 Japan Active Implantable Devices Revenue YoY Growth 2015-2026
6.1.3 Japan Active Implantable Devices Market Share in Global Market 2015-2026
6.2 Japan Active Implantable Devices Market Size by Players (International and Local Players)
6.2.1 Japan Top Active Implantable Devices Players by Sales (2015-2020)
6.2.2 Japan Top Active Implantable Devices Players by Revenue (2015-2020)
6.3 Japan Active Implantable Devices Historic Market Review by Type (2015-2020)
6.3.1 Japan Active Implantable Devices Sales Market Share by Type (2015-2020)
6.3.2 Japan Active Implantable Devices Revenue Market Share by Type (2015-2020)
6.3.3 Japan Active Implantable Devices Price by Type (2015-2020)
6.4 Japan Active Implantable Devices Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Active Implantable Devices Sales Forecast by Type (2021-2026)
6.4.2 Japan Active Implantable Devices Revenue Forecast by Type (2021-2026)
6.4.3 Japan Active Implantable Devices Price Forecast by Type (2021-2026)
6.5 Japan Active Implantable Devices Historic Market Review by Application (2015-2020)
6.5.1 Japan Active Implantable Devices Sales Market Share by Application (2015-2020)
6.5.2 Japan Active Implantable Devices Revenue Market Share by Application (2015-2020)
6.5.3 Japan Active Implantable Devices Price by Application (2015-2020)
6.6 Japan Active Implantable Devices Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Active Implantable Devices Sales Forecast by Application (2021-2026)
6.6.2 Japan Active Implantable Devices Revenue Forecast by Application (2021-2026)
6.6.3 Japan Active Implantable Devices Price Forecast by Application (2021-2026)
7 North America
7.1 North America Active Implantable Devices Market Size YoY Growth 2015-2026
7.2 North America Active Implantable Devices Market Facts & Figures by Country
7.2.1 North America Active Implantable Devices Sales by Country (2015-2020)
7.2.2 North America Active Implantable Devices Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Active Implantable Devices Market Size YoY Growth 2015-2026
8.2 Europe Active Implantable Devices Market Facts & Figures by Country
8.2.1 Europe Active Implantable Devices Sales by Country
8.2.2 Europe Active Implantable Devices Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Active Implantable Devices Market Size YoY Growth 2015-2026
9.2 Asia Pacific Active Implantable Devices Market Facts & Figures by Country
9.2.1 Asia Pacific Active Implantable Devices Sales by Region (2015-2020)
9.2.2 Asia Pacific Active Implantable Devices Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Active Implantable Devices Market Size YoY Growth 2015-2026
10.2 Latin America Active Implantable Devices Market Facts & Figures by Country
10.2.1 Latin America Active Implantable Devices Sales by Country
10.2.2 Latin America Active Implantable Devices Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Active Implantable Devices Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Active Implantable Devices Market Facts & Figures by Country
11.2.1 Middle East and Africa Active Implantable Devices Sales by Country
11.2.2 Middle East and Africa Active Implantable Devices Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 LivaNova PLC (U.K.)
12.1.1 LivaNova PLC (U.K.) Corporation Information
12.1.2 LivaNova PLC (U.K.) Description and Business Overview
12.1.3 LivaNova PLC (U.K.) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 LivaNova PLC (U.K.) Active Implantable Devices Products Offered
12.1.5 LivaNova PLC (U.K.) Recent Development
12.2 MED-EL (Austria)
12.2.1 MED-EL (Austria) Corporation Information
12.2.2 MED-EL (Austria) Description and Business Overview
12.2.3 MED-EL (Austria) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 MED-EL (Austria) Active Implantable Devices Products Offered
12.2.5 MED-EL (Austria) Recent Development
12.3 Medtronic (Ireland)
12.3.1 Medtronic (Ireland) Corporation Information
12.3.2 Medtronic (Ireland) Description and Business Overview
12.3.3 Medtronic (Ireland) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Medtronic (Ireland) Active Implantable Devices Products Offered
12.3.5 Medtronic (Ireland) Recent Development
12.4 Abbott Laboratories (U.S.)
12.4.1 Abbott Laboratories (U.S.) Corporation Information
12.4.2 Abbott Laboratories (U.S.) Description and Business Overview
12.4.3 Abbott Laboratories (U.S.) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Abbott Laboratories (U.S.) Active Implantable Devices Products Offered
12.4.5 Abbott Laboratories (U.S.) Recent Development
12.5 BIOTRONIK (Germany)
12.5.1 BIOTRONIK (Germany) Corporation Information
12.5.2 BIOTRONIK (Germany) Description and Business Overview
12.5.3 BIOTRONIK (Germany) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 BIOTRONIK (Germany) Active Implantable Devices Products Offered
12.5.5 BIOTRONIK (Germany) Recent Development
12.6 Boston Scientific Corporation (U.S.)
12.6.1 Boston Scientific Corporation (U.S.) Corporation Information
12.6.2 Boston Scientific Corporation (U.S.) Description and Business Overview
12.6.3 Boston Scientific Corporation (U.S.) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Boston Scientific Corporation (U.S.) Active Implantable Devices Products Offered
12.6.5 Boston Scientific Corporation (U.S.) Recent Development
12.7 Cochlear Limited (Australia)
12.7.1 Cochlear Limited (Australia) Corporation Information
12.7.2 Cochlear Limited (Australia) Description and Business Overview
12.7.3 Cochlear Limited (Australia) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Cochlear Limited (Australia) Active Implantable Devices Products Offered
12.7.5 Cochlear Limited (Australia) Recent Development
12.8 Nurotron Biotechnology (China)
12.8.1 Nurotron Biotechnology (China) Corporation Information
12.8.2 Nurotron Biotechnology (China) Description and Business Overview
12.8.3 Nurotron Biotechnology (China) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Nurotron Biotechnology (China) Active Implantable Devices Products Offered
12.8.5 Nurotron Biotechnology (China) Recent Development
12.9 Sonova Holding Switzerland)
12.9.1 Sonova Holding Switzerland) Corporation Information
12.9.2 Sonova Holding Switzerland) Description and Business Overview
12.9.3 Sonova Holding Switzerland) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sonova Holding Switzerland) Active Implantable Devices Products Offered
12.9.5 Sonova Holding Switzerland) Recent Development
12.10 William Demant Holding (Denmark)
12.10.1 William Demant Holding (Denmark) Corporation Information
12.10.2 William Demant Holding (Denmark) Description and Business Overview
12.10.3 William Demant Holding (Denmark) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 William Demant Holding (Denmark) Active Implantable Devices Products Offered
12.10.5 William Demant Holding (Denmark) Recent Development
12.11 LivaNova PLC (U.K.)
12.11.1 LivaNova PLC (U.K.) Corporation Information
12.11.2 LivaNova PLC (U.K.) Description and Business Overview
12.11.3 LivaNova PLC (U.K.) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 LivaNova PLC (U.K.) Active Implantable Devices Products Offered
12.11.5 LivaNova PLC (U.K.) Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Active Implantable Devices Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Active Implantable Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Active Implantable Devices Market Segments
Table 2. Ranking of Global Top Active Implantable Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Active Implantable Devices Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Implantable Cardioverter Defibrillator
Table 5. Major Manufacturers of Implantable Cardiac Pacemakers
Table 6. Major Manufacturers of Ventricular Assist Devices
Table 7. Major Manufacturers of Implantable Heart Monitors/Insertable Loop Recorders
Table 8. Major Manufacturers of Neurostimulators
Table 9. Major Manufacturers of Implantable Hearing Devices
Table 10. Global Active Implantable Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Active Implantable Devices Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Active Implantable Devices Sales by Regions 2015-2020 (K Units)
Table 13. Global Active Implantable Devices Sales Market Share by Regions (2015-2020)
Table 14. Global Active Implantable Devices Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Active Implantable Devices Sales Forecast by Region (2021-2026) (K Units)
Table 16. Global Active Implantable Devices Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Active Implantable Devices Sales Share by Manufacturers (2015-2020)
Table 18. Global Active Implantable Devices Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Active Implantable Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Implantable Devices as of 2019)
Table 20. Active Implantable Devices Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Active Implantable Devices Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Active Implantable Devices Price (2015-2020) (USD/Unit)
Table 23. Active Implantable Devices Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Active Implantable Devices Product Type
Table 25. Date of International Manufacturers Enter into Active Implantable Devices Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Active Implantable Devices Sales by Type (2015-2020) (K Units)
Table 28. Global Active Implantable Devices Sales Share by Type (2015-2020)
Table 29. Global Active Implantable Devices Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Active Implantable Devices Revenue Share by Type (2015-2020)
Table 31. Active Implantable Devices Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Active Implantable Devices Sales Share by Type (2021-2026)
Table 33. Global Active Implantable Devices Sales by Application (2015-2020) (K Units)
Table 34. Global Active Implantable Devices Sales Share by Application (2015-2020)
Table 35. Global Active Implantable Devices Sales Share by Application (2021-2026)
Table 36. Global Active Implantable Devices Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Active Implantable Devices Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Active Implantable Devices Revenue Market Share Forecast by Application (2021-2026)
Table 39. Japan Active Implantable Devices Sales (K Units) of Key Companies (2015-2020)
Table 40. Japan Active Implantable Devices Sales Share by Company (2015-2020)
Table 41. Japan Active Implantable Devices Revenue (US$ Million) by Company (2015-2020)
Table 42. Japan Active Implantable Devices Sales (K Units) by Type (2015-2020)
Table 43. Japan Active Implantable Devices Sales Share by Type (2015-2020)
Table 44. Japan Active Implantable Devices Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. Japan Active Implantable Devices Price (K Units) by Type (2015-2020)
Table 46. Japan Active Implantable Devices Sales (K Units) by Type (2021-2026)
Table 47. Japan Active Implantable Devices Sales Share by Type (2021-2026)
Table 48. Japan Active Implantable Devices Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. Japan Active Implantable Devices Revenue Share by Type (2021-2026)
Table 50. Japan Active Implantable Devices Price (K Units) by Type (2021-2026)
Table 51. Japan Active Implantable Devices Sales (K Units) by Application (2015-2020)
Table 52. Japan Active Implantable Devices Sales Share by Application (2015-2020)
Table 53. Japan Active Implantable Devices Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. Japan Active Implantable Devices Sales (K Units) by Application (2021-2026)
Table 55. Japan Active Implantable Devices Sales Share by Application (2021-2026)
Table 56. Japan Active Implantable Devices Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. Japan Active Implantable Devices Revenue Share by Application (2021-2026)
Table 58. North America Active Implantable Devices Sales by Country (2015-2020) (K Units)
Table 59. North America Active Implantable Devices Sales Market Share by Country (2015-2020)
Table 60. North America Active Implantable Devices Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Active Implantable Devices Revenue Market Share by Country (2015-2020)
Table 62. Europe Active Implantable Devices Sales by Country (2015-2020) (K Units)
Table 63. Europe Active Implantable Devices Sales Market Share by Country (2015-2020)
Table 64. Europe Active Implantable Devices Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Active Implantable Devices Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Active Implantable Devices Sales by Region (2015-2020) (K Units)
Table 67. Asia Pacific Active Implantable Devices Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Active Implantable Devices Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Active Implantable Devices Revenue Market Share by Region (2015-2020)
Table 70. Latin America Active Implantable Devices Sales by Country (2015-2020) (K Units)
Table 71. Latin America Active Implantable Devices Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Active Implantable Devices Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Active Implantable Devices Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Active Implantable Devices Sales by Country (2015-2020) (K Units)
Table 75. Middle East and Africa Active Implantable Devices Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Active Implantable Devices Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Active Implantable Devices Revenue Market Share by Country (2015-2020)
Table 78. LivaNova PLC (U.K.) Corporation Information
Table 79. LivaNova PLC (U.K.) Description and Business Overview
Table 80. LivaNova PLC (U.K.) Active Implantable Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. LivaNova PLC (U.K.) Active Implantable Devices Product
Table 82. LivaNova PLC (U.K.) Recent Development
Table 83. MED-EL (Austria) Corporation Information
Table 84. MED-EL (Austria) Description and Business Overview
Table 85. MED-EL (Austria) Active Implantable Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. MED-EL (Austria) Product
Table 87. MED-EL (Austria) Recent Development
Table 88. Medtronic (Ireland) Corporation Information
Table 89. Medtronic (Ireland) Description and Business Overview
Table 90. Medtronic (Ireland) Active Implantable Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Medtronic (Ireland) Product
Table 92. Medtronic (Ireland) Recent Development
Table 93. Abbott Laboratories (U.S.) Corporation Information
Table 94. Abbott Laboratories (U.S.) Description and Business Overview
Table 95. Abbott Laboratories (U.S.) Active Implantable Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Abbott Laboratories (U.S.) Product
Table 97. Abbott Laboratories (U.S.) Recent Development
Table 98. BIOTRONIK (Germany) Corporation Information
Table 99. BIOTRONIK (Germany) Description and Business Overview
Table 100. BIOTRONIK (Germany) Active Implantable Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. BIOTRONIK (Germany) Product
Table 102. BIOTRONIK (Germany) Recent Development
Table 103. Boston Scientific Corporation (U.S.) Corporation Information
Table 104. Boston Scientific Corporation (U.S.) Description and Business Overview
Table 105. Boston Scientific Corporation (U.S.) Active Implantable Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Boston Scientific Corporation (U.S.) Product
Table 107. Boston Scientific Corporation (U.S.) Recent Development
Table 108. Cochlear Limited (Australia) Corporation Information
Table 109. Cochlear Limited (Australia) Description and Business Overview
Table 110. Cochlear Limited (Australia) Active Implantable Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Cochlear Limited (Australia) Product
Table 112. Cochlear Limited (Australia) Recent Development
Table 113. Nurotron Biotechnology (China) Corporation Information
Table 114. Nurotron Biotechnology (China) Description and Business Overview
Table 115. Nurotron Biotechnology (China) Active Implantable Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Nurotron Biotechnology (China) Product
Table 117. Nurotron Biotechnology (China) Recent Development
Table 118. Sonova Holding Switzerland) Corporation Information
Table 119. Sonova Holding Switzerland) Description and Business Overview
Table 120. Sonova Holding Switzerland) Active Implantable Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Sonova Holding Switzerland) Product
Table 122. Sonova Holding Switzerland) Recent Development
Table 123. William Demant Holding (Denmark) Corporation Information
Table 124. William Demant Holding (Denmark) Description and Business Overview
Table 125. William Demant Holding (Denmark) Active Implantable Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. William Demant Holding (Denmark) Product
Table 127. William Demant Holding (Denmark) Recent Development
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Active Implantable Devices Players
Table 132. Active Implantable Devices Customers List
Table 133. Active Implantable Devices Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Implantable Devices Product Picture
Figure 2. Global Active Implantable Devices Sales Market Share by Type in 2020 & 2026
Figure 3. Implantable Cardioverter Defibrillator Product Picture
Figure 4. Implantable Cardiac Pacemakers Product Picture
Figure 5. Ventricular Assist Devices Product Picture
Figure 6. Implantable Heart Monitors/Insertable Loop Recorders Product Picture
Figure 7. Neurostimulators Product Picture
Figure 8. Implantable Hearing Devices Product Picture
Figure 9. Global Active Implantable Devices Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Active Implantable Devices Report Years Considered
Figure 13. Global Active Implantable Devices Market Size 2015-2026 (US$ Million)
Figure 14. Global Active Implantable Devices Sales 2015-2026 (K Units)
Figure 15. Global Active Implantable Devices Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Active Implantable Devices Sales Market Share by Region (2015-2020)
Figure 17. Global Active Implantable Devices Sales Market Share by Region in 2019
Figure 18. Global Active Implantable Devices Revenue Market Share by Region (2015-2020)
Figure 19. Global Active Implantable Devices Revenue Market Share by Region in 2019
Figure 20. Global Active Implantable Devices Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Active Implantable Devices Revenue in 2019
Figure 22. Active Implantable Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Active Implantable Devices Sales Market Share by Type (2015-2020)
Figure 24. Global Active Implantable Devices Sales Market Share by Type in 2019
Figure 25. Global Active Implantable Devices Revenue Market Share by Type (2015-2020)
Figure 26. Global Active Implantable Devices Revenue Market Share by Type in 2019
Figure 27. Global Active Implantable Devices Market Share by Price Range (2015-2020)
Figure 28. Global Active Implantable Devices Sales Market Share by Application (2015-2020)
Figure 29. Global Active Implantable Devices Sales Market Share by Application in 2019
Figure 30. Global Active Implantable Devices Revenue Market Share by Application (2015-2020)
Figure 31. Global Active Implantable Devices Revenue Market Share by Application in 2019
Figure 32. Japan Active Implantable Devices Sales Growth Rate 2015-2026 (K Units)
Figure 33. Japan Active Implantable Devices Revenue Growth Rate 2015-2026 (US$ Million)
Figure 34. Japan Active Implantable Devices Market Share in Global Market 2015-2026
Figure 35. Japan 5 and 10 Largest Active Implantable Devices Players Market Share by Revenue in Active Implantable Devices in 2019
Figure 36. Japan Active Implantable Devices Revenue Share by Type (2015-2020)
Figure 37. Japan Active Implantable Devices Revenue Growth Rate by Type in 2015 & 2019
Figure 38. Japan Active Implantable Devices Revenue Share by Application (2015-2020)
Figure 39. Japan Active Implantable Devices Revenue Growth Rate by Application in 2015 & 2019
Figure 40. North America Active Implantable Devices Sales Growth Rate 2015-2020 (K Units)
Figure 41. North America Active Implantable Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. North America Active Implantable Devices Sales Market Share by Country in 2019
Figure 43. North America Active Implantable Devices Revenue Market Share by Country in 2019
Figure 44. U.S. Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 45. U.S. Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Canada Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 47. Canada Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Europe Active Implantable Devices Sales Growth Rate 2015-2020 (K Units)
Figure 49. Europe Active Implantable Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe Active Implantable Devices Sales Market Share by Country in 2019
Figure 51. Europe Active Implantable Devices Revenue Market Share by Country in 2019
Figure 52. Germany Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 53. Germany Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 55. France Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 57. U.K. Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 59. Italy Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 61. Russia Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Asia Pacific Active Implantable Devices Sales Growth Rate 2015-2020 (K Units)
Figure 63. Asia Pacific Active Implantable Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Active Implantable Devices Sales Market Share by Region in 2019
Figure 65. Asia Pacific Active Implantable Devices Revenue Market Share by Region in 2019
Figure 66. China Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 67. China Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 69. Japan Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 71. South Korea Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 73. India Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 75. Australia Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 77. Taiwan Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 79. Indonesia Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 81. Thailand Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 83. Malaysia Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 85. Philippines Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Active Implantable Devices Sales Growth Rate (2015-2020) (K Units)
Figure 87. Vietnam Active Implantable Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Latin America Active Implantable Devices Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Active Implantable Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Active Implantable Devices Sales Market Share by Country in 2019
Figure 91. Latin America Active Implantable Devices Revenue Market Share by Country in 2019
Figure 92. Mexico Active Implantable Devices Sales Growth R
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs